Status:
UNKNOWN
Anticardiolipin Autoantibodies and Mortality in Septic Patients
Lead Sponsor:
Military Hospital of Tunis
Conditions:
Morality
Eligibility:
All Genders
18+ years
Brief Summary
The detection of antiphospholipid antibodies (aPL) is of interest because of their importance in the pathogenesis of arterial or venous thrombosis and their responsibility for a wide spectrum of clini...
Detailed Description
the investigators conducted a prospective single-center observational study including consecutive critically ill septic adults admitted to the intensive care unit. Clinical and laboratory data includi...
Eligibility Criteria
Inclusion
- patients, admitted to the ICU for sepsis and older than 18 years
Exclusion
- pregnancy
- clinical history of antiphospholipid syndrome
- auto-immune diseases
- immunosuppressive treatment
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04685278
Start Date
October 1 2020
End Date
February 15 2021
Last Update
December 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Military Hospital of Tunisia
Tunis, Tunisia, 1008